2m 2m 2m 2m 2m 2m 2m
Alkermes (ALKS)
NASDAQ
$46.00+$0.02 (+0.05%)
Price as of Sep 11, 2026 7:30 PM EDT- $7.6BMarket Cap
- 70.45%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Alkermes (ALKS)
$46.00+$0.02 (+0.05%)
ALKS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $45.97 | ||
Change | -$0.14 (-0.30%) | ||
Open | $46.75 | ||
High | $46.75 | ||
Low | $45.73 | ||
Previous Close | $46.11 | ||
Volume | 1,344,228 | ||
30-Day Average Volume | 1,288,706 | ||
1-Week Change | -0.28% | ||
1-Month Change | -6.58% | ||
1-Year Change | 70.45% | ||
3-Year Change | 55.72% | ||
5-Year Change | 50.62% | ||
Fundamentals | |||
Shares Outstanding | 164.8M | ||
Total Assets | $4.4B | ||
Market Cap | $7.6B | ||
Enterprise Value | $8.6B | ||
Period: QTR TTM FY | |||
Revenue | $411.7M | ||
Net Income | $501,000.00 | ||
Free Cash Flow | $137.0M | ||
EBIT | $5.5M | ||
EBITDA | $35.8M | ||
Net Working Capital | $860.8M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 239 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 4 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 55 | ||
Price/Operating Cash Flow | 52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue